SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

TJ Biopharma Announces Publication of Plonmarlimab Phase 2 Results

The findings were published in the Journal of Hematology & Oncology.

Related stories